Evidence map›Paper›PMID 26823866›Full record

ArticleInternational journal of clinical and experimental pathology2015

Association of PTEN gene polymorphisms with liver cancer risk.

Hong-Guang Li, Fang-Feng Liu, Hua-Qiang Zhu, Xu Zhou, Jun Lu, Hong Chang, Jin-Hua Hu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Autophagic Inhibition of Caveolin-1 by CompoundFrontiers in pharmacology · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Journal of thoracic disease · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hong-Guang LiDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Fang-Feng LiuDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Hua-Qiang ZhuDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Xu ZhouDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Jun LuDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Hong ChangDepartment of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Jin-Hua HuDepartment of Gastroenterology Surgery, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250021, Shandong, China.
Shandong Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo find out if there are any relationship between three single nucleotide polymorphisms (SNPs) of phosphatase and tensin homolog (PTEN) gene (rs1234213, rs1234220, and rs2299939) and the susceptibility of liver cancer.

methodsGenotypes of the three SNPs in the PTEN gene were achieved utilizing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Comparison of genotypes and alleles distribution differences between the case and the control subjects was accomplished with χ(2) test. The analysis of linkage disequilibrium (LD) and haplotypes of the three SNPs was performed using SHEsis software. We adopted odds ratios (ORs) with 95% confidence intervals (95% CIs) to show the relative risk of liver cancer.

resultsTC genotype and C allele of rs1234220 polymorphism showed much more frequently in cases than in controls, reflecting that the TC genotype and the C allele may be linked to the increased risk of liver cancer (OR=2.225, 95% CI=1.178-4.204; OR=1.941, 95% CI=1.124-3.351). Rs2299939 polymorphism showed an opposite result that the GT genotype probably reduce the risk of liver cancer (OR=0.483, 95% CI=0.259-0.900). Statistical significance was not found in the distribution differences of the genotypes of rs1234213 between two groups. LD and haplotype analysis results of the three SNPs showed that the T-C-G haplotype frequency was much higher in cases than in healthy objects, which proved that the T-C-G haplotype might be a susceptibility haplotype for liver cancer (OR=3.750, 95% CI=1.396-10.077).

conclusionsPTEN gene polymorphisms might relate to liver cancer risk.

Indexed as

Polymorphism, Single NucleotideAdultAgedCase-Control StudiesFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansLinkage DisequilibriumLiver NeoplasmsMaleMiddle AgedOdds RatioPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthPTEN PhosphohydrolasePTEN protein, humanhaplotypeliver cancerpolymorphismPTEN

Identifiers

PMID26823866
PMCPMC4713652
OpenAlexW2418697561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.